Table of Content

1 Vaccine Adjuvant Market Introduction and Overview
1.1 Vaccine Adjuvant Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Vaccine Adjuvant Industry Dynamic Analysis
1.5.1 Vaccine Adjuvant Market Trends Analysis
1.5.2 Vaccine Adjuvant Market Drivers Analysis
1.5.3 Vaccine Adjuvant Market Challenges Analysis
1.5.4 Vaccine Adjuvant Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Vaccine Adjuvant Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Vaccine Adjuvant Revenue and Share by Type
3 Global Vaccine Adjuvant Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Vaccine Adjuvant Revenue and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Vaccine Adjuvant Market Size (2019-2024)
4.2 Vaccine Adjuvant Growth Insights by Regions
4.2.1 Vaccine Adjuvant Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Vaccine Adjuvant Revenue Market Size by Regions (2019-2024)
4.2.3 North America Vaccine Adjuvant Market Size (2019-2024)
4.2.4 Europe Vaccine Adjuvant Market Size (2019-2024)
4.2.5 Asia-Pacific Vaccine Adjuvant Market Size (2019-2024)
4.2.6 Latin America Vaccine Adjuvant Market Size (2019-2024)
4.2.7 Middle East & Africa Vaccine Adjuvant Market Size (2019-2024)
5 North America
5.1 North America Vaccine Adjuvant Revenue by Countries
5.1.1 North America Vaccine Adjuvant Revenue by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Vaccine Adjuvant Revenue by Countries
6.1.1 Asia Pacific Vaccine Adjuvant Revenue by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Vaccine Adjuvant Revenue by Countries
7.1.1 Europe Vaccine Adjuvant Revenue by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Vaccine Adjuvant Revenue by Countries
8.1.1 Latin America Vaccine Adjuvant Revenue by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Vaccine Adjuvant Revenue by Countries
9.1.1 Middle East & Africa Vaccine Adjuvant Revenue by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Vaccine Adjuvant Market Competition, by Players
10.1 Global Vaccine Adjuvant Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Vaccine Adjuvant Players Market Share in 2023
10.2.2 Top 6 Vaccine Adjuvant Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Vaccine Adjuvant Players Head Office, Business Provided
10.4 Vaccine Adjuvant Mergers & Acquisitions
10.5 Vaccine Adjuvant New Entrants and Expansion Plans
11 Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Profile
11.1.2 Vaccine Adjuvant Product Overview
11.1.3 GlaxoSmithKline Vaccine Adjuvant Market Performance (2019-2024)
11.1.4 GlaxoSmithKline Business Overview
11.1.5 Recent Developments and Plans
11.2 Novavax
11.2.1 Novavax Company Profile
11.2.2 Vaccine Adjuvant Product Overview
11.2.3 Novavax Vaccine Adjuvant Market Performance (2019-2024)
11.2.4 Novavax Business Overview
11.2.5 Recent Developments and Plans
11.3 SPI Pharma
11.3.1 SPI Pharma Company Profile
11.3.2 Vaccine Adjuvant Product Overview
11.3.3 SPI Pharma Vaccine Adjuvant Market Performance (2019-2024)
11.3.4 SPI Pharma Business Overview
11.3.5 Recent Developments and Plans
11.4 Agenus
11.4.1 Agenus Company Profile
11.4.2 Vaccine Adjuvant Product Overview
11.4.3 Agenus Vaccine Adjuvant Market Performance (2019-2024)
11.4.4 Agenus Business Overview
11.4.5 Recent Developments and Plans
11.5 CSL Limited
11.5.1 CSL Limited Company Profile
11.5.2 Vaccine Adjuvant Product Overview
11.5.3 CSL Limited Vaccine Adjuvant Market Performance (2019-2024)
11.5.4 CSL Limited Business Overview
11.5.5 Recent Developments and Plans
11.6 InvivoGen
11.6.1 InvivoGen Company Profile
11.6.2 Vaccine Adjuvant Product Overview
11.6.3 InvivoGen Vaccine Adjuvant Market Performance (2019-2024)
11.6.4 InvivoGen Business Overview
11.6.5 Recent Developments and Plans
11.7 Brenntag Biosector
11.7.1 Brenntag Biosector Company Profile
11.7.2 Vaccine Adjuvant Product Overview
11.7.3 Brenntag Biosector Vaccine Adjuvant Market Performance (2019-2024)
11.7.4 Brenntag Biosector Business Overview
11.7.5 Recent Developments and Plans
12 Global Vaccine Adjuvant Forecast Market Insights by Type
12.1 Global Vaccine Adjuvant Revenue Market Forecast by Type (2024-2030)
13 Global Vaccine Adjuvant Forecast Market Insights by Application
13.1 Vaccine Adjuvant Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Insights
14.1 Global Vaccine Adjuvant Forecast Market Size (2024-2030)
14.2 Vaccine Adjuvant Growth Forecast Insights by Regions
14.2.1 Vaccine Adjuvant Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Vaccine Adjuvant Forecast Market Size (2024-2030)
14.2.3 Europe Vaccine Adjuvant Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Vaccine Adjuvant Forecast Market Size (2024-2030)
14.2.5 Latin America Vaccine Adjuvant Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Vaccine Adjuvant Forecast Market Size (2024-2030)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer